Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Arch Phys Med Rehabil. 2017 Aug 31;99(1):99–106. doi: 10.1016/j.apmr.2017.07.013

Table 3.

Differences in outcomes between groups over time

Outcome Measure HIGH QAB 1 Month Mean (SEE) N LOW QAB 1 Month Mean (SEE) N Difference Between Groups at 1 month Point estimate (95% CI) p-value Effect Size HIGH QAB 2 Months Mean (SEE) N LOW QAB 2 Months Mean (SEE) N Difference Between Groups at 2 months Point estimate (95% CI) p-value Effect Size
Stair Climbing Test (s) 21.7 (0.6)
71
26.6 (0.6)
86
−4.9 (−6.6, −3.3)
<0.001
0.56 14.2 (0.6)
69
16.1 (0.6)
84
−1.9 (−3.5, −0.3)
0.02
0.53
Timed Up and Go Test (s) 9.7 (0.2)
71
11.3 (0.2)
86
−1.6 (−2.1, −1.1)
<0.001
0.61 8.0 (0.2)
69
8.5 (0.2)
84
−0.5 (−1.0, 0.0)
0.04
0.39
6-minute Walk Test (m) 408 (7)
71
372 (6)
86
37 (18, 55)
<0.001
0.54 477 (7)
69
464 (6)
84
13 (−5, 31)
0.16
0.18
Quadriceps Strength (nM/kg) 0.85 (0.04)
71
0.73 (0.03)
84
0.12 (0.02, 0.21)
0.01
0.49 1.13 (0.04)
68
1.03 (0.03)
84
0.09 (0.00, 0.19)
0.06
0.40
Activation (%) 76.0 (1.6)
63
70.3 (1.6)
64
5.8 (1.2, 10.3)
0.01
0.34 81.4 (1.7)
62
79.9 (1.6)
65
1.5 (−3.0, 6.1)
0.52
0.17

Estimates are based on a Maximum Likelihood model for repeated measures controlling for baseline, sex, site, and treatment group. Abbreviations: QAB, quadriceps activation battery; SEE, standard error of the estimate.